1. Home
  2. VIGL vs CSBR Comparison

VIGL vs CSBR Comparison

Compare VIGL & CSBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VIGL
  • CSBR
  • Stock Information
  • Founded
  • VIGL 2020
  • CSBR 1985
  • Country
  • VIGL United States
  • CSBR United States
  • Employees
  • VIGL N/A
  • CSBR N/A
  • Industry
  • VIGL Biotechnology: Pharmaceutical Preparations
  • CSBR Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • VIGL Health Care
  • CSBR Health Care
  • Exchange
  • VIGL Nasdaq
  • CSBR Nasdaq
  • Market Cap
  • VIGL 134.9M
  • CSBR 111.4M
  • IPO Year
  • VIGL 2022
  • CSBR 1986
  • Fundamental
  • Price
  • VIGL $8.05
  • CSBR $8.33
  • Analyst Decision
  • VIGL Buy
  • CSBR Strong Buy
  • Analyst Count
  • VIGL 7
  • CSBR 1
  • Target Price
  • VIGL $8.00
  • CSBR $12.00
  • AVG Volume (30 Days)
  • VIGL 1.1M
  • CSBR 39.6K
  • Earning Date
  • VIGL 08-12-2025
  • CSBR 09-10-2025
  • Dividend Yield
  • VIGL N/A
  • CSBR N/A
  • EPS Growth
  • VIGL N/A
  • CSBR N/A
  • EPS
  • VIGL N/A
  • CSBR 0.46
  • Revenue
  • VIGL N/A
  • CSBR $58,591,000.00
  • Revenue This Year
  • VIGL N/A
  • CSBR $15.11
  • Revenue Next Year
  • VIGL N/A
  • CSBR $7.80
  • P/E Ratio
  • VIGL N/A
  • CSBR $17.71
  • Revenue Growth
  • VIGL N/A
  • CSBR 19.03
  • 52 Week Low
  • VIGL $1.31
  • CSBR $3.60
  • 52 Week High
  • VIGL $8.06
  • CSBR $11.99
  • Technical
  • Relative Strength Index (RSI)
  • VIGL 88.18
  • CSBR 64.00
  • Support Level
  • VIGL $7.86
  • CSBR $7.16
  • Resistance Level
  • VIGL $8.05
  • CSBR $9.63
  • Average True Range (ATR)
  • VIGL 0.02
  • CSBR 0.64
  • MACD
  • VIGL -0.15
  • CSBR 0.11
  • Stochastic Oscillator
  • VIGL 73.15
  • CSBR 69.06

About VIGL Vigil Neuroscience Inc.

Vigil Neuroscience Inc is a clinical-stage biotechnology company engaged in improving the lives of patients, caregivers, and families affected by rare and common neurodegenerative diseases by pursuing the development of disease-modifying therapeutics to restore the vigilance of microglia. Microglia are the sentinel immune cells of the brain and play a critical role in maintaining central nervous system (CNS) health and responding to damage caused by disease. The group provides solutions for fully human monoclonal antibody and Oral small molecule TERM2 agonist.

About CSBR Champions Oncology Inc.

Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.

Share on Social Networks: